466 related articles for article (PubMed ID: 23598475)
1. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
[TBL] [Abstract][Full Text] [Related]
2. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
3. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
4. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
5. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
Gandhi G; Lydon P
BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
[TBL] [Abstract][Full Text] [Related]
6. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
7. Funding gap for immunization across 94 low- and middle-income countries.
Ozawa S; Grewal S; Portnoy A; Sinha A; Arilotta R; Stack ML; Brenzel L
Vaccine; 2016 Dec; 34(50):6408-6416. PubMed ID: 28029541
[TBL] [Abstract][Full Text] [Related]
8. Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
Sim SY; Watts E; Constenla D; Huang S; Brenzel L; Patenaude BN
Value Health; 2021 Jan; 24(1):70-77. PubMed ID: 33431156
[TBL] [Abstract][Full Text] [Related]
9. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
10. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
[TBL] [Abstract][Full Text] [Related]
11. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
12. Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.
Shen AK; Weiss JM; Andrus JK; Pecenka C; Atherly D; Taylor K; McQuestion M
Health Aff (Millwood); 2016 Feb; 35(2):272-6. PubMed ID: 26858380
[TBL] [Abstract][Full Text] [Related]
13. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.
Wolfson LJ; Gasse F; Lee-Martin SP; Lydon P; Magan A; Tibouti A; Johns B; Hutubessy R; Salama P; Okwo-Bele JM
Bull World Health Organ; 2008 Jan; 86(1):27-39. PubMed ID: 18235887
[TBL] [Abstract][Full Text] [Related]
14. An analysis of how the GAVI alliance and low- and middle-income countries can share costs of new vaccines.
Saxenian H; Cornejo S; Thorien K; Hecht R; Schwalbe N
Health Aff (Millwood); 2011 Jun; 30(6):1122-33. PubMed ID: 21653966
[TBL] [Abstract][Full Text] [Related]
15. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
16. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
17. Tracking financial flows for immunization in Honduras.
Valdés W; Janusz CB; Molina Aguilera IB; Mendoza L; Díaz IY; Resch S
Vaccine; 2015 May; 33 Suppl 1():A85-92. PubMed ID: 25919182
[TBL] [Abstract][Full Text] [Related]
18. Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries.
Stenberg K; Hanssen O; Edejer TT; Bertram M; Brindley C; Meshreky A; Rosen JE; Stover J; Verboom P; Sanders R; Soucat A
Lancet Glob Health; 2017 Sep; 5(9):e875-e887. PubMed ID: 28728918
[TBL] [Abstract][Full Text] [Related]
19. Routes Countries Can Take To Achieve Full Ownership Of Immunization Programs.
McQuestion M; Carlson A; Dari K; Gnawali D; Kamara C; Mambu-Ma-Disu H; Mbwanque J; Kizza D; Silver D; Paatashvili E
Health Aff (Millwood); 2016 Feb; 35(2):266-71. PubMed ID: 26858379
[TBL] [Abstract][Full Text] [Related]
20. Global support for new vaccine implementation in middle-income countries.
Kaddar M; Schmitt S; Makinen M; Milstien J
Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]